A Study to Assess Efficacy of RXC004 +/- Nivolumab in Ring Finger Protein 43 (RNF43) or R-spondin (RSPO) Aberrated, Metastatic, Microsatellite Stable, Colorectal Cancer After Progression on Standard of Care (SOC)
Phase 2 Completed
25 enrolled 22 charts
Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004
Phase 4 Completed
85 enrolled 13 charts
Study to Determine Treatment Effects of Denosumab in Patients With Breast Cancer Receiving Aromatase Inhibitor Therapy
Phase 3 Completed
3,420 enrolled 19 charts
A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects.
Phase 3 Completed
2,049 enrolled 16 charts
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma
Phase 3 Completed
1,718 enrolled 22 charts
Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma.
Phase 3 Completed
1,779 enrolled 14 charts
A Real-world Study on Patients of Unresectable Giant Cell Tumor of Bone
Completed
301 enrolled
Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
Phase 2 Completed
226 enrolled 24 charts
MW032
Phase 1 Completed
120 enrolled
Open-Label Access Protocol of Denosumab for Subjects With Advanced Cancer
Phase 3 Completed
129 enrolled 10 charts
Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer
Phase 3 Completed
384 enrolled 8 charts
AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-metastatic Breast Cancer
Phase 3 Completed
252 enrolled 13 charts
AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-metastatic Prostate Cancer
Phase 3 Completed
1,468 enrolled 24 charts
Study on Prolonging Bone Metastasis-Free Survival in Men With Hormone Refractory Prostate Cancer
Phase 3 Completed
1,435 enrolled 15 charts
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Phase 2 Completed
33 enrolled 22 charts
Study to Compare the Efficacy and Safety of DenosumAb Versus Placebo in Males With Osteoporosis
Phase 3 Completed
242 enrolled 19 charts
Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Men With Hormone-refractory Prostate Cancer
Phase 3 Completed
1,904 enrolled 15 charts
Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss
Phase 3 Completed
769 enrolled 21 charts
A Study to Compare Denosumab With Zoledronic Acid in Subjects With Bone Metastases From Solid Tumors
Phase 3 Completed
487 enrolled 13 charts
Denosumab for Prolonging Bone Metastasis-Free Survival in Men With Hormone-Refractory Prostate Cancer
Phase 3 Completed
18 enrolled 13 charts
Open Label Extension to SRE Studies in United Kingdom and Czech Republic Only
Phase 3 Completed
35 enrolled 8 charts
Denosumab (AMG 162) in Bisphosphonate Naive Metastatic Breast Cancer
Phase 2 Completed
255 enrolled 34 charts
Study of AMG 162 in Subjects With Advanced Cancer Currently Being Treated With Intravenous (IV) Bisphosphonates
Phase 2 Completed
111 enrolled 20 charts